| Item |
Cat. No. |
Application |
Isotype |
| Anti-Salmonella typhi mAbs [AC04 [268/376] ](MABL-2865) |
MABL-2865 |
Engineer |
Salmonella typhi |
| Anti-salmon GST-rho mAbs [R0-3](MABL-2864) |
MABL-2864 |
Engineer |
Fish, Salmon |
| Anti-SALL4 mAbs [RAB-C191](MABL-2863) |
MABL-2863 |
Engineer |
Human |
| Anti-SALL1 mAbs [RAB-T53](MABL-2862) |
MABL-2862 |
Engineer |
Human |
| Anti-SAG1 mAbs [Tox203](MABL-2861) |
MABL-2861 |
Engineer |
Toxoplasma gondii |
| Anti-Sag1 mAbs [4F11E12](MABL-2860) |
MABL-2860 |
Engineer |
Toxoplasma gondii |
| Anti-S100A9 mAbs [IID4B10](MABL-2859) |
MABL-2859 |
Engineer |
Human |
| Anti-S100A8 & S100A9 mAbs [5.5](MABL-2858) |
MABL-2858 |
Engineer |
Human |
| Anti-S. aureus β-GlcNAc WTA mAbs [4497](MABL-2857) |
MABL-2857 |
Engineer |
Staphylococcus aureus |
| Anti-RuvC mAbs [RuvC 5G9/3](MABL-2856) |
MABL-2856 |
Engineer |
E.coli |
| Anti-RuvC mAbs [7F1/5](MABL-2855) |
MABL-2855 |
Engineer |
E.coli |
| Anti-RT1-D mAbs [OX-17](MABL-2854) |
MABL-2854 |
Engineer |
Rat |
| Anti-RSV F protein mAbs [MEDI-493 (Palivizumab, hu129)](MABL-2853) |
MABL-2853 |
Engineer |
RSV |
| Anti-RSPO2 mAbs [h130M23-H1L2](MABL-2852) |
MABL-2852 |
Engineer |
Human, Mouse |
| Anti-RSPO1 mAbs [89M5](MABL-2851) |
MABL-2851 |
Engineer |
Human, Mouse |
| Anti-RRM2 mAbs [SAIC-30E-7](MABL-2850) |
MABL-2850 |
Engineer |
Human |
| Anti-RRM2 mAbs [SAIC-30C-18](MABL-2849) |
MABL-2849 |
Engineer |
Human |
| Anti-RPRD1A mAbs [RAB-C113](MABL-2848) |
MABL-2848 |
Engineer |
Human |
| Anti-Rpp30 mAbs [6E12](MABL-2847) |
MABL-2847 |
Engineer |
Human |
| Anti-ROS1 mAbs [ROS1-5F2](MABL-2846) |
MABL-2846 |
Engineer |
Human |
